NIH to evaluate remdesivir treatment for COVID during pregnancy
Por um escritor misterioso
Descrição
WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]
Messages from the COVID-19 Response Task Force
Therapeutic dilemmas in addressing SARS-CoV-2 infection
Clinical outcomes of hospitalized COVID-19 patients treated with
Mild or Moderate Covid-19
Frontiers Therapeutic Effectiveness and Safety of Repurposing
Therapeutic Management of Nonhospitalized Adults With COVID-19
13 Things To Know About Paxlovid, the Latest COVID-19 Pill > News
Management Strategies in Children and Adolescents with Mild to
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid
de
por adulto (o preço varia de acordo com o tamanho do grupo)
